Ambrx Biopharma Cayman, Inc. Quarterly Common Stock, Shares, Issued from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2023 was 432M shares, a 59.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 432M +162M +59.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 386M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 270M +335K +0.12% Dec 31, 2022 10-Q 2023-08-09
Q2 2022 270M Jun 30, 2022 6-K 2022-08-29
Q4 2021 270M +270M +158794% Dec 31, 2021 10-K 2023-03-30
Q4 2020 170K* Dec 31, 2020 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.